Kaupinen Wes
SEC insider (Form 3/4/5 filer). CIK 0001918142. President and CEO at PALVELLA THERAPEUTICS, INC. (PVLA). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 5, 2026. Located in WAYNE, PA.
Companies Kaupinen Wes has filed insider reports for
- PALVELLA THERAPEUTICS, INC. (PVLA): Director, Officer, 10% Owner, President and CEO
Kaupinen Wes
CIK: 0001918142
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PALVELLA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 5, 2026PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
124.6K shares- - Feb 5, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectNon-Qualified Stock Option (right to buy)
243.8K shares- - Dec 13, 2024PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
417.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 5, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 124,603 | - | - | Direct |
| Feb 5, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Non-Qualified Stock Option (right to buy) | 243,831 | - | - | Direct |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 417,806 | - | - | Direct |
1-3 of 3 transactions